Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?
Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur Graph Search.
Concept
Intima–media thickness
Résumé
Intima–media thickness (IMT), also called intimal medial thickness, is a measurement of the thickness of tunica intima and tunica media, the innermost two layers of the wall of an artery. The measurement is usually made by external ultrasound and occasionally by internal, invasive ultrasound catheters. Measurements of the total wall thickness of blood vessels can also be done using other imaging modalities.
Carotid IMT is used to detect the presence of atherosclerosis in humans and, more contentiously, to track the regression, arrest or progression of atherosclerosis. Ultrasound measurements of carotid IMT were first proposed and validated in vitro by Paolo Pignoli in 1984 and further details were subsequently published in a highly cited article. The use of IMT as a non-invasive tool to track changes in arterial walls has increased substantially since the mid-1990s. Although carotid IMT is predictive of future cardiovascular events, the usefulness of measuring change in carotid IMT over time is disputed, as meta-analyses have not found that change in carotid IMT is predictive of cardiovascular events. As such, the use of change in carotid IMT as a surrogate endpoint measure of drug efficacy in clinical trials, or in clinical management of cardiovascular disease, is debated.
Carotid IMT is occasionally used in clinical practice, but its role is not clear. After systematically reviewing the evidence base, the United States Preventive Services Task Force found no support for its routine use in stratification of risk for people at intermediate cardiovascular risk. However, in 2003 the European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension recommended the use of carotid IMT measurements in high-risk patients to help identify target organ damage and in 2010 the American Heart Association and the American College of Cardiology advocated the use of carotid IMT on intermediate risk patients if usual risk classification was not satisfactory.
Source officielle
À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.